Citius Pharma (NASDAQ:CTXR) just reported results for the third quarter of 2024.
- Citius Pharma reported earnings per share of -6 cents. This met the analyst estimate for EPS of -6 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
Citius Pharma (NASDAQ:CTXR) just reported results for the third quarter of 2024.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/ctxr-stock-earnings-citius-pharma-for-q3-of-2024/.
©2025 InvestorPlace Media, LLC